Diagnostic role of inflammatory and anti‐inflammatory cytokines and effector molecules of cytotoxic T lymphocytes in tuberculous pleural effusion

Early diagnosis of tuberculous pleural effusion (TPE) remains difficult. While some inflammatory markers in pleural effusion (PE) are helpful in diagnosis, the roles of anti‐inflammatory cytokines and effector molecules of cytotoxic T lymphocytes have not been investigated.

[1]  E. Marchi,et al.  Proinflammatory and antiinflammatory cytokine levels in complicated and noncomplicated parapneumonic pleural effusions. , 2012, Chest.

[2]  R. Light,et al.  Clinical practice. Pleural effusion. , 2002, The New England journal of medicine.

[3]  A. Gozu,et al.  Tumour necrosis factor-alpha in comparison to adenosine deaminase in tuberculous pleuritis. , 2003, Respiration; international review of thoracic diseases.

[4]  S. Albelda,et al.  Tuberculous pleural effusions. , 1987, Chest.

[5]  J. M. Porcel,et al.  Comparison of polymorphonuclear- and lymphocyte-rich tuberculous pleural effusions. , 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[6]  R. Pandey,et al.  Cytokine Polarization in Miliary and Pleural Tuberculosis , 2002, Journal of Clinical Immunology.

[7]  Pan‐Chyr Yang,et al.  Mycobacterium tuberculosis and polymorphonuclear pleural effusion: incidence and clinical pointers. , 2009, Respiratory medicine.

[8]  L. Tanoue,et al.  American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States. , 2005, American journal of respiratory and critical care medicine.

[9]  F. Khan,et al.  Diagnostic value of pleural fluid interferon-gamma and adenosine deaminase in patients with pleural tuberculosis in Qatar , 2013, International journal of general medicine.

[10]  R. Krenke,et al.  Pleural fluid adenosine deaminase and interferon gamma as diagnostic tools in tuberculosis pleurisy. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[11]  A. Mohan,et al.  Adenosine deaminase in the diagnosis of tuberculosis pleural effusion. , 1996, The Indian journal of chest diseases & allied sciences.

[12]  Jou-Wei Lin,et al.  Revisiting tuberculous pleurisy: pleural fluid characteristics and diagnostic yield of mycobacterial culture in an endemic area , 2012, Thorax.

[13]  A. Garcia-Zamalloa,et al.  Diagnostic Accuracy of Adenosine Deaminase and Lymphocyte Proportion in Pleural Fluid for Tuberculous Pleurisy in Different Prevalence Scenarios , 2012, PloS one.

[14]  Robert H. Pratt,et al.  Trends in tuberculosis--United States, 2008. , 2009, MMWR. Morbidity and mortality weekly report.

[15]  N. Weng,et al.  The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation , 2012, Nature Reviews Immunology.

[16]  Chong-Jen Yu,et al.  In-hospital outcome of patients with culture-confirmed tuberculous pleurisy: clinical impact of pulmonary involvement , 2011, BMC infectious diseases.

[17]  E. Bateman,et al.  Clinical Diagnostic Utility of IP-10 and LAM Antigen Levels for the Diagnosis of Tuberculous Pleural Effusions in a High Burden Setting , 2009, PloS one.

[18]  A. Mohan,et al.  Extrapulmonary Tuberculosis , 2019, Springer International Publishing.

[19]  A. Gozu,et al.  Tumour Necrosis Factor-α in Comparison to Adenosine Deaminase in Tuberculous Pleuritis , 2003, Respiration.

[20]  Chong-Jen Yu,et al.  Evaluating pleural ADA, ADA2, IFN-γ and IGRA for diagnosing tuberculous pleurisy. , 2013, The Journal of infection.

[21]  C. Nahoum.  Inflammation and Infection , 1982 .

[22]  Shin-Hwar Wu,et al.  Soluble Fas ligand is another good diagnostic marker for tuberculous pleurisy. , 2010, Diagnostic microbiology and infectious disease.

[23]  S. Sahn,et al.  Diagnosis and treatment of tuberculous pleural effusion in 2006. , 2007, Chest.

[24]  Huanzhong Shi,et al.  Diagnostic Value of Interferon-γ in Tuberculous Pleurisy: A Metaanalysis , 2007 .

[25]  D. Jiménez Castro,et al.  ADA-JADAp ratio in pleural tuberculosis: an excellent diagnostic parameter in pleural fluid , 2004 .

[26]  Huanzhong Shi,et al.  Diagnostic value of interferon-gamma in tuberculous pleurisy: a metaanalysis. , 2007, Chest.

[27]  P. Barnes,et al.  Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. , 1989, Journal of immunology.

[28]  R. Light,et al.  Update on tuberculous pleural effusion , 2010, Respirology.

[29]  Y. Chen,et al.  Differential diagnosis of tuberculous and malignant pleurisy using pleural fluid adenosine deaminase and interferon gamma in Taiwan. , 2011, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[30]  Wan-Wan Lin,et al.  Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer. , 2011, Biochemical pharmacology.

[31]  Chong-Jen Yu,et al.  Apoptosis-associated biomarkers in tuberculosis: promising for diagnosis and prognosis prediction , 2013, BMC Infectious Diseases.

[32]  M. Selman,et al.  A functional promoter polymorphism in monocyte chemoattractant protein–1 is associated with increased susceptibility to pulmonary tuberculosis , 2005, The Journal of experimental medicine.

[33]  B. Premack,et al.  Chemokine receptors: Gateways to inflammation and infection , 1996, Nature Medicine.

[34]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[35]  H. Oral,et al.  Increased Pleural Soluble Fas Ligand (sFasL) Levels in Tuberculosis Pleurisy and Its Relation with T-helper Type 1 Cytokines , 2008, Lung.